New Program Offers Affordable Hepatitis B Treatments in the US
Telemedicine Consult - Dr. Gish
Schedule Telemedicine Consult with Dr. Gish Powered byTelemed2U
Powered byTelemed2U

New Program Offers Affordable Hepatitis B Treatments in the US

New Rx Outreach Program Offers Affordable Hepatitis B Medications for Patients in the United States

Are you a hepatitis B patient living in the United States? Are you taking entecavir or tenofovir disoproxil fumarate (TDF) to help manage your hepatitis B infection? Good news! Rx Outreach – America’s largest fully licensed, non-profit, mail order pharmacy and Patient Assistance Program –will now have access to tenofovir disoproxil fumarate (TDF) and entecavir, two front-line medications used to treat hepatitis B, at prices significantly lower than retail. 

Tenofovir disoproxil fumarate (TDF), generic Viread ®, retails for $838.85 for a 30-day supply but is available from Rx Outreach for $25 for up to 30 tablets. Entecavir, generic Baraclude ®, has an average monthly retail price of $981.66, but is available from Rx Outreach for $45 for up to 30 tablets. Individuals who meet the eligibility requirements will qualify for Rx Outreach’s affordable pricing regardless of their health insurance status or prescription coverage.

Eligibility is based on income. To determine if you are eligible, and to order medications from Rx Outreach, visit www.rxoutreach.org/hepb.


Metadata